BioRestorative Therapies, Inc. Email Format

Biotechnology ResearchNew York, United States11-50 Employees

BioRestorative Therapies, Inc. is a biotechnology research company based in Melville, New York, focused on cell- and tissue-based therapies derived from adult stem cells. The firm organizes its work around two core programs—Disc/Spine and Metabolic—each aiming to translate stem cell biology into therapeutic options. In the Disc/Spine program, BRTX-100 uses autologous mesenchymal stem cells from a patient's bone marrow, intended as a non-surgical treatment for protruding and bulging lumbar discs in chronic lumbar disc disease, with outpatient delivery by a physician after an FDA-cleared Phase 2 pathway. The Metabolic Program, branded ThermoStem, seeks to generate brown adipose tissue from brown adipose-derived stem cells to regulate energy and metabolic parameters related to obesity and metabolic disorders. In 2026 the company disclosed a strategic collaboration with 203 Creates to develop and commercialize a biocosmeceutical platform.

Get verified BioRestorative Therapies, Inc. emails free

Company overview Employee directory